📣 VC round data is live. Check it out!

Nordhealth Valuation Multiples

Discover Nordhealth's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Value HR, Spok, EM Systems Co., MTI Ltd. and more.

Nordhealth Overview

About Nordhealth

Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship products are Provet Cloud and EasyPractice, both cloud-based Practice Management Software for veterinarians and therapists, respectively. It builds software that empowers healthcare professionals to improve patient care, increase efficiency and expand their business. The company has two operating segments namely: Veterinary and Therapy. It operates geographically in Norway, which derives maximum revenue, Finland, the United Kingdom, Sweden, Denmark, Germany and Other countries.


Founded

2021

HQ

Norway

Employees

411

Financials (LTM)

Revenue: $62M
EBITDA: $2M

EV

$205M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Nordhealth Financials

Nordhealth reported last 12-month revenue of $62M and EBITDA of $2M.

In the same LTM period, Nordhealth generated $50M in gross profit, $2M in EBITDA, and had net loss of ($14M).

Revenue (LTM)


Nordhealth P&L

In the most recent fiscal year, Nordhealth reported revenue of $59M and EBITDA of $1M.

Nordhealth is unprofitable as of last fiscal year, with gross margin of 81%, EBITDA margin of 2%, and net margin of (25%).

See analyst estimates for Nordhealth
LTMLast FY202320242025202620272028
Revenue$62M$59M$43M$53M$59M
Gross Profit$50M$48M$37M$45M$48M
Gross Margin81%81%86%85%81%
EBITDA$2M$1M($767K)$5M($1M)
EBITDA Margin3%2%(2%)9%(2%)
EBIT Margin(19%)(20%)(31%)(17%)(25%)
Net Profit($14M)($15M)($13M)($9M)($15M)
Net Margin(23%)(25%)(30%)(17%)(25%)

Financial data powered by Morningstar, Inc.

Nordhealth Stock Performance

Nordhealth has current market cap of $223M, and enterprise value of $205M.

Market Cap Evolution


Nordhealth's stock price is $2.83.

Nordhealth share price decreased by 4.6% in the last 30 days, and by 28.7% in the last year.

Nordhealth has an EPS (earnings per share) of $-0.19.

See more trading valuation data for Nordhealth
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$205M$223M-4.0%-4.6%-3.9%-28.7%$-0.19

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Nordhealth Valuation Multiples

Nordhealth trades at 3.3x EV/Revenue multiple, and 117.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Nordhealth

EV / Revenue (LTM)


Nordhealth Financial Valuation Multiples

As of June 3, 2026, Nordhealth has market cap of $223M and EV of $205M.

Nordhealth has a P/E ratio of (15.4x).

LTMLast FY202320242025202620272028
EV/Revenue3.3x3.5x4.8x3.9x3.5x
EV/EBITDA117.4x177.5xn/m41.9x(182.9x)
EV/EBIT(17.7x)(17.7x)(15.5x)(22.9x)(14.2x)
EV/Gross Profit4.1x4.3x5.6x4.5x4.3x
P/E(15.4x)(15.1x)(17.2x)(25.0x)(15.1x)
EV/FCF(49.5x)(44.4x)(16.1x)(55.7x)(40.4x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Nordhealth Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Nordhealth Margins & Growth Rates

Nordhealth grew revenue by 10% and EBITDA by 121% in the last fiscal year.

In the most recent fiscal year, Nordhealth reported gross margin of 81%, EBITDA margin of 2%, and net margin of (25%).

See estimated margins and future growth rates for Nordhealth

Nordhealth Margins

Last FY202420252026202720282029
Gross Margin81%85%81%79%
EBITDA Margin2%9%(2%)4%
EBIT Margin(20%)(17%)(25%)(18%)
Net Margin(25%)(17%)(25%)(21%)
FCF Margin(8%)(7%)(9%)(5%)

Nordhealth Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth10%24%11%10%
Gross Profit Growth7%23%6%7%
EBITDA Growth121%(739%)(123%)(328%)
EBIT Growth1%(32%)61%(20%)
Net Profit Growth(8%)(31%)65%(8%)
FCF Growth(25%)(71%)38%(31%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Nordhealth Operational KPIs

Nordhealth's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.

Nordhealth's Rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Nordhealth's Rule of X is 30% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Nordhealth
LTMLast FY202320242025202620272028
Rule of 4014%14%---
Bessemer Rule of X30%30%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue-3%4%4%3%
G&A Expenses to Revenue-3%4%3%3%
Opex to Revenue-106%117%102%106%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Nordhealth Competitors

Nordhealth competitors include Value HR, Spok, EM Systems Co., MTI Ltd., Kusurinomadoguchi, CE Holdings, eWeLL, AdvancedAdvT, Optima Health and Ever Fortune.AI.

Most Nordhealth public comparables operate across Healthcare Software, B2B SaaS, Vertical SaaS and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Value HR3.6x3.6x26.5x-
Spok1.6x1.6x7.5x7.6x
EM Systems Co.1.1x1.1x5.3x5.8x
MTI Ltd.0.6x0.6x2.9x3.7x
Kusurinomadoguchi2.4x2.1x9.0x6.7x
CE Holdings1.4x1.4x8.2x-
eWeLL7.4x6.8x15.2x13.9x
AdvancedAdvT2.6x-11.0x-

This data is available for Pro users. Sign up to see all Nordhealth competitors and their valuation data.

Start Free Trial

Acquisitions by Nordhealth

Nordhealth has acquired 3 companies to date.

Last acquisition by Nordhealth was on March 10th 2022. Nordhealth acquired Vetera for $9M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Nordhealth

Vetera
EasyPractice
Aspit
Description
Vetera is a software provider offering integrated practice management solutions for veterinary clinics. Its cloud-based systems handle scheduling, billing, inventory, and client communications across multiple locations worldwide.
-
Aspit is a Norwegian supplier of electronic health record systems and IT services tailored for chiropractors, physiotherapists, and psychiatry practices. Headquartered in Oslo, the company integrates patient management, billing, and telehealth features into its cloud-based platforms.
HQ CountryGermanyDenmarkNorway
HQ City
Frankfurt
-
Seljord
Deal Date10 Mar 202231 Jan 20222 Jun 2021
Valuation$9M$16M$52M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Nordhealth acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Nordhealth

When was Nordhealth founded?Nordhealth was founded in 2021.
Where is Nordhealth headquartered?Nordhealth is headquartered in Norway.
How many employees does Nordhealth have?As of today, Nordhealth has over 411 employees.
Is Nordhealth publicly listed?Yes, Nordhealth is a public company listed on Oslo Børs.
What is the stock symbol of Nordhealth?Nordhealth trades under NORDH ticker.
When did Nordhealth go public?Nordhealth went public in 2021.
Who are competitors of Nordhealth?Nordhealth main competitors include Value HR, Spok, EM Systems Co., MTI Ltd., Kusurinomadoguchi, CE Holdings, eWeLL, AdvancedAdvT, Optima Health, Ever Fortune.AI.
What is the current market cap of Nordhealth?Nordhealth's current market cap is $223M.
What is the current revenue of Nordhealth?Nordhealth's last 12 months revenue is $62M.
What is the current revenue growth of Nordhealth?Nordhealth revenue growth (NTM/LTM) is 11%.
What is the current EV/Revenue multiple of Nordhealth?Current revenue multiple of Nordhealth is 3.3x.
What is the current EBITDA of Nordhealth?Nordhealth's last 12 months EBITDA is $2M.
What is Nordhealth's EBITDA margin?Nordhealth's last 12 months EBITDA margin is 3%.
What is the current EV/EBITDA multiple of Nordhealth?Current EBITDA multiple of Nordhealth is 117.4x.
What is the current FCF of Nordhealth?Nordhealth's last 12 months FCF is ($4M).
What is Nordhealth's FCF margin?Nordhealth's last 12 months FCF margin is (7%).
What is the current EV/FCF multiple of Nordhealth?Current FCF multiple of Nordhealth is (49.5x).
How many companies Nordhealth has acquired to date?As of June 2026, Nordhealth has acquired 3 companies.
What was the largest acquisition by Nordhealth?$52M acquisition of Aspit on 2nd June 2021 was the largest M&A Nordhealth has done to date.
What companies Nordhealth acquired?Nordhealth acquired Aspit, EasyPractice, and Vetera.
In how many companies Nordhealth has invested to date?Nordhealth hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Nordhealth

Lists including Nordhealth

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial